Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited.
Isolation of putative cancer stem cells (CSCs) in various tumors has generated much excitement among researchers who consider these cells the potential "culprits" behind resistance to conventional therapy. Both cancer and cardiovascular disease are believed to be stem cell disorders involving circulating endothelial progenitors (CEPs) and mesenchymal stem cells (MSCs). CD133 and CD44, markers of CSCs in many tumors, also enrich CEPs and MSCs, respectively. We propose an integrated tumorigenesis model that involves all three interdependent stem cell (CSC, CEP, MSC) compartments by revisiting the "seed and soil" model. Developing therapeutics that can effectively target CSCs and spare normal cardiovascular tissue will remain a challenge. Preliminary laboratory and clinical data on monitoring and targeting colon CSCs, using such a modeling system, are discussed.
Lin
Edward H
EH
Division of Medical Oncology and Hematology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA.
Jiang
Yixing
Y
Deng
Yanhong
Y
Lapsiwala
Ritu
R
Lin
Tongyu
T
Blau
C Anthony
CA